Is Psychiatry Ignoring Suicide?
Authors:
- Mark SinyorMSMark Sinyor
- Gary RemingtonGRGary Remington
- 1 June 2012
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 32 (3) , 307-308
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Absolute Risk of Suicide After First Hospital Contact in Mental DisorderArchives of General Psychiatry, 2011
- Managing Suicide Risk in Patients with SchizophreniaCNS Drugs, 2011
- Reassessing the Long-term Risk of Suicide After a First Episode of PsychosisArchives of General Psychiatry, 2010
- Where to Position Clozapine: Re-Examining the EvidenceThe Canadian Journal of Psychiatry, 2010
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)The Lancet, 2009
- Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patientsSchizophrenia Research, 2007
- The history of clozapine and its emergence in the US marketHistory of Psychiatry: Madness, Science, Culture, 2007
- Suicide in Schizophrenia, Clozapine, and Adoption of Evidence-Based MedicineThe Journal of Clinical Psychiatry, 2005
- Suicidal risk during treatment with clozapine: a meta-analysisSchizophrenia Research, 2005
- CONDITIONS PREDISPOSING TO SUICIDEJournal of Nervous & Mental Disease, 1977